PATENT CLAIM ANALYSIS

Application Number: 15746182
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["544", "008000"]

Abstract:
The invention provides a series of chlorobenzene substituted azaaryl compounds having activity in inhibiting cancer cell growth and low toxicity to normal cells. Particularly, the compounds of the invention have stronger inhibition effect on bladder cancer and liver cancer.

Claim (Index 15):
A method for inhibiting, preventing or treating a cancer in a subject, comprising administering to the subject an effective amount of the compound of  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.23529
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15230700', '13391148', '11570966', '13575799', '15181903']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7153783526093674
- 35 USC 102 Novelty (BERT): 0.5176093832309068
- Combined Prediction Score: 0.6956014556715214
- Mean Citation Score: 260.94092800000004
- Max Citation Score: 291.13596
- Similarity Product: 191.60188792087555

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test